Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging

Expert Opinion on Therapeutic Targets

Volumn 16, Issue 7, 2012, Pages 677-688

  Stȩpień, Ewa ^a   Kabłak Ziembicka, Anna ^a   Czyz, Jarosław ^b   Przewłocki, Tadeusz ^a   Małecki, Maciej ^a,c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

Author keywords

actin remodeling; calcium influx; cell communication; diabetic retinopathy; microparticles; microRNA; neoangiogenesis; vascular aging

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 12; CALCIUM; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; THROMBOPLASTIN;

AGING; ANGIOGENESIS; ATHEROSCLEROSIS; CALCIUM CELL LEVEL; CELL COMMUNICATION; CELL MEMBRANE; CELL VACUOLE; DIABETIC RETINOPATHY; HUMAN; MICROPARTICLE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; VASCULAR ENDOTHELIUM;

AGING; ANIMALS; CELL-DERIVED MICROPARTICLES; DIABETIC RETINOPATHY; ENDOTHELIUM, VASCULAR; HUMANS;

EID: 84862581745     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2012.691471     Document Type: Review

References (82)

1. Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011;31:27-33
2. Orozco AF, Lewis DE. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A 2010;77:502-14
3. Tushuizen ME, Diamant M, Sturk A, et al. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe? Arterioscler Thromb Vasc Biol 2011;31:4-9 Current review revealing harmful role of microparticles in cardiovascular diseases.
4. Nomura S. Dynamic role of microparticles in type 2 diabetes mellitus. Curr Diabetes Rev 2009;5:245-51 Outstanding summary of microparticles regulation in diabetes.
5. Morel O, Jesel L, Freyssinet JM, et al. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 2011;31:15-26
6. Ratajczak J, Miekus K, Kucia M, et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006;20:847-56
7. Chironi GN, Boulanger CM, Simon A, et al. Endothelial microparticles in diseases. Cell Tissue Res 2009;335:143-51
8. Rautou PE, Vion AC, Amabile N, et al. Microparticles, vascular function, and atherothrombosis. Circ Res 2011;109:593-606 Important review summarizing atherothrombotic and atheroprotective activity of MPs.
9. Curtis AM, Wilkinson PF, Gui M, et al. p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles. J Thromb Haemost 2009;7:701-9
10. Sapet C, Simoncini S, Loriod B, et al. Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. Blood 2006;108:1868-76 (Pubitemid 44394996)
11. Simoncini S, Njock MS, Robert S, et al. TRAIL/Apo2L mediates the release of procoagulant endothelial microparticles induced by thrombin in vitro: a potential mechanism linking inflammation and coagulation. Circ Res 2009;104:943-51
12. Leroyer AS, Anfosso F, Lacroix R, et al. Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb Haemost 2010;104:456-63
13. Daleke DL. Regulation of transbilayer plasma membrane phospholipid asymmetry. J Lipid Res 2003;44:233-42 Master review of the maintenance of transbilayer lipid asymmetry and mechanisms leading to the disruption of this asymmetry: flippase, floppase, and scramblase activity. (Pubitemid 37303867)
14. Sekuła M, Janawa G, Stankiewicz E, et al. Endothelial microparticle formation in moderate concentrations of homocysteine and methionine in vitro. Cell Mol Biol Lett 2011;16:69-78
15. Kim HK, Song KS, Chung JH, et al. Platelet microparticles induce angiogenesis in vitro. Br J Haematol 2004;124:376-84 (Pubitemid 38167990)
16. Muralidharan-Chari V, Clancy JW, Sedgwick A, et al. Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 2010;123:1603-11 Key review on the properties and biogenesis of microvesicles and their potential role in cell-to-cell communication.
17. Stepien E, Gruca A, Grzybowska J, et al. Different population of platelet derived microparticles from healthy donors stimulate angiogenesis in vitro. Cardiovasc Res 2012;93(Suppl):S75
18. Dainiak N, Riordan MA, Strauss PR, et al. Contractile proteins participate in release of erythroid growth regulators from mononuclear cells. Blood 1988;72:165-71 The first and fundamental study on actin polymerization in microvesicles release.
19. Cauwenberghs S, Feijge MA, Harper AG, et al. Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton. FEBS Lett 2006;580:5313-20 Good study showing involvement of calcium and αIIbβ3 signaling and in MPs formation. (Pubitemid 44415813)
20. Manno S, Takakuwa Y, Mohandas N. Identification of a functional role for lipid asymmetry in biological membranes: phosphatidylserine-skeletal protein interactions modulate membrane stability. Proc Natl Acad Sci USA 2002;99:1943-8 Key description of interactions between aminophospholipids and cytoskeletal proteins (i.e., spectrin) in modulating cell membrane stability. (Pubitemid 34168994)
21. Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010;107:1047-57 Current views on cell- and tissue-specific mechanisms of MP formation and release.
22. Czyz J, Szpak K, Madeja Z. The role of connexins in prostate cancer promotion and progression. Nat Rev Urol 2012;9:274-82
23. Stepien E. Acceleration of new biomarkers development and discovery in synergistic diagnostics of coronary artery disease, coronary angiography - advances in noninvasive imaging approach for evaluation of coronary artery disease. In: Baskot B, editor. InTech; 2011. Available from: http://www.intechopen.com
24. Jimenez JJ, Jy W, Mauro L, et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003;109:175-80 (Pubitemid 36712905)
25. Janowska-Wieczorek A, Majka M, Kijowski J, et al. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 2001;98:3143-9
26. Barry OP, Pratico D, Lawson JA, et al. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997;99:2118-27 (Pubitemid 27203768)
27. Zampetaki A, Willeit P, Tilling L, et al. Prospective study on circulating microRNAs and risk of myocardial infarction. Cardiovasc Res 2012;93(Suppl):S43
28. Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008;3:e3694 The first study profiling the miRNA expression in circulating plasma microvesicles.
29. Raitoharju E, Lyytikainen LP, Levula M, et al. miR-21, miR-210,miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 2011;219:211-17
30. Mezentsev A, Merks RMH, O'Riordan E, et al. Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol Heart Circ Physiol 2005;289:H1106-14 (Pubitemid 41208953)
31. Leroyer AS, Rautou PE, Silvestre JS, et al. CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. J Am Coll Cardiol 2008;52:1302-11
32. Gordon EM, Venkatesan N, Salazar R, et al. Factor XII-induced mitogenesis is mediated via a distinctsignal transduction pathway that activates a mitogen-activated protein kinase. Proc Natl Acad Sci USA 1996;93:2174-9 (Pubitemid 26079901)
33. Zhou H, Shi W, Zhou B, et al. Tissue factor-factor VIIa regulates interleukin-8, tissue factor and caspase-7 expression in SW620 cells through protease-activated receptor-2 activation. Mol Med Rep 2010;3:269-74
34. Diamant M, Nieuwland R, Pablo RF, et al. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 2002;106:2442-7 (Pubitemid 35278799)
35. Tsimerman G, Roguin A, Bachar A, et al. Involvement of microparticles in diabetic vascular complications. Thromb Haemost 2011;106:310-21
36. Hjortoe GM, Petersen LC, Albrektsen T. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood 2004;103:3029-37 (Pubitemid 38451676)
37. Chahed S, Leroyer AS, Benzerroug M, et al. Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation. Diabetes 2010;59:694-701
38. Rao VR, Prescott E, Shelke NB, et al. Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin (STZ) model of diabetic retinopathy (DR). Invest Ophthalmol Vis Sci 2010;51:5198-204
39. McArthur K, Feng B, Wu Y, et al. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes 2011;60:1314-23 Study showing a novel mechanism of DR including a downregulation of miR-200b.
40. Silva VA, Polesskaya A, Sousa TA, et al. Expression and cellular localization of microRNA-29b and RAX, an activator of the RNA-dependent protein kinase (PKR), in the retina of streptozotocin-induced diabetic rats. Mol Vis 2011;17:2228-40
41. Staszel T, Zapała B, Polus A, et al. Role of microRNAs in endothelial cell pathophysiology. Pol Arch Med Wewn 2011;121:361-6
42. Lacroix R, Robert S, Poncelet P, et al. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2010;8:2571-4
43. Morel O, Morel N, Jesel L, et al. Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis. Semin Immunopathol 2011;33:469-86
44. Wang JM, Yang Z, Xu MG, et al. Berberine-induced decline in circulationg CD31+/CD42- microparticles is associated with improvement of endothelial function in humans. Eur J Pharmacol 2009;614:77-83
45. Cheng F, Wang Y, Li J, et al. Berberine improves endothelial function be reducing endothelial microparticles-mediated oxidative stress in humans. Int J Cardiol 2012;In press
46. Nomura S, Suzuki M, Katsura K, et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 1995;116:235-40
47. Koga H, Sugiyama S, Kugiyama K, et al. Elevated levels of VE-cadherin-positive endothelial microparticles inpatients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005;45:1622-30 (Pubitemid 40704497)
48. Tan KT, Tayebjee HM, Lim HS. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels. Diabet Med 2005;22:1657-62 (Pubitemid 43046464)
49. Bulut D, Maier K, Bulut-Streich N, et al. Circulating endothelial microparticles corretate inversely with endothelial function in patients with ischemic left ventricular dysfunction. J Card Fail 2008;14:336-40 (Pubitemid 351636235)
50. Bulut D, Tuns H, Mugge A. CD31+/Annexin V+ microparticles in healthy offsprings of patients with coronary artery disease. Eur J Clin Invest 2009;39:17-22
51. Chirinos JA, Heresi GA, Velasquez H, et al. Elevation of endothelial microparticles,platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005;45:1467-71 (Pubitemid 40615620)
52. Bal L, Ederhy S, Di Angelantonio E, et al. Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism. Arch Cardiovasc Dis 2010;103:394-403
53. Bal L, Ederhy S, Di Angelantonio E, et al. Circulationg procoagulant microparticles in acute pulmonary embolism; a case-control study. Int J Cardiol 2010;145:321-2
54. Garcia Rodriguez P, Eikenboom HC, Tesselaar ME, et al. Plasma levels of microparticle-associated tissues factor activity in patients with clinically suspected pulmonary embolism. Thromb Res 2010;126:345-9
55. Steppich BA, Hassenpflug M, Braun SL, et al. Circulating tissue factor and microparticles are not increased in patients with deep vein thrombosis. Vasa 2011;40:117-22
56. Campello E, Spiezia L, Radu CM, et al. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. Thromb Res 2011;127:473-7
57. Morel O, Hugel B, Jesel L, et al. Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus. Thromb Haemost 2004;91:345-53 (Pubitemid 38240181)
58. van der Zee PM, Biro E, Ko Y, et al. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 2006;52:657-64
59. Stepien E, Stankiewicz E, Zalewski J, et al. Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation. Arch Med Res 2012;43:31-5
60. Preston RA, Jy W, Jimenez JJ, et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003;41:211-17 (Pubitemid 36204891)
61. Wang JM, Su C, Wang Y, et al. Elevated circulating endothelial microparticles and brachial-ankle pulse wave velocity in well-controlled hypertensive patients. J Hum Hypertens 2009;23:307-15
62. Amabile N, Heiss C, Real WM, et al. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 2008;177:1268-75 (Pubitemid 351860937)
63. Diehl P, Aleker M, Helbing T, et al. Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension. J Thromb Thrombolysis 2011;31:173-9
64. Simak J, Gelderman MP, Yu H, et al. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost 2006;4:1296-302
65. Jung K-H, Chu K, Lee S-T, et al. Circulatig endothelial microparticles as a marker of cerebrovascular disease. Ann Neurol 2009;66:191-9
66. Kuriyama N, Nagakane Y, Hosomi A, et al. Evaluation factors associated with elevated levels of platelet-derived microparticles in the acute phase of cerebral infarction. Clin Appl Thromb Hemost 2010;16:26-32
67. Łukasik M, Rozalski M, Luzak B, et al. Platelet activation and reactivity in the convalescent phase of ischemic stroke. Thromb Haemost 2010;103:644-50
68. Lackner P, Dietmann A, Beer R, et al. Cellular microparticles as a marker for cerebral vasospasm in spontaneous subarachnoid hemorrhage. Stroke 2010;41:2353-7
69. Amabile N, Guerin AP, Leroyer A, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005;16:3381-8 (Pubitemid 46179341)
70. Faure V, Dou L, Sabatier F, et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 2006;4:566-73
71. Daniel L, Fakhouri F, Joly D, et al. Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int 2006;69:1416-23
72. Dursun I, Poyrazoglu HM, Gunduz Z, et al. The relationship between circulating endothelial microparticles and arterial stiffness and atheosclerosis in children with chronic kidney disease. Nephrol Dial Transplant 2009;24:2511-18
73. Huang PH, Huang SS, Chen YH, et al. Increased circulating CD31+/annexin V+ apoptotic microaprticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria. J Hypertens 2010;28:1655-65
74. Jayachandran M, Litwiller R, Owen WG, et al. Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol 2008;295:H931-8
75. Stepien E, Stolinski J, Grzybowska J, et al. Potential role of platelet derived microparticles and their aggregates in atherosclerotic plaque vascularization. Cardiovasc Res 2012;93(Suppl):S76
76. Fortunato O, Caporali A, Sangalli E, et al. MicroRNA-15a and mir-16 regulate sdf-1 migration of endothelial progenitor cells in diabetic patients with limb ischemia and healthy controls. Cardiovasc Res 2012;93(Suppl):S34
77. Maegdefessel L, Azuma J, Toh R, et al. MicroRNAs -21 and -29b regulate abdominal aortic aneurysm expansion. Cardiovasc Res 2012;93(Suppl):S83
78. Gambacciani C, Chiavacci E, Evangelista M, et al. miR-29 and miR-30 are involved in cardiac epigenetic reprogramming after myocardial infarction and ischemia. Cardiovasc Res 2012;93(Suppl):S54
79. De Pauw A, Sekkali B, Friart A, et al. Inhibition of endogenous Wnt/beta-catenin following miR29a downregulation mediates differentiation of Cardiac Stem Cells into cardiomyocytes. Cardiovasc Res 2012;93(Suppl):S99
80. Zhang H. Sweeney D,Thomas GN, et al. The role of miR-29b/collagen Type I/BMP-1 pathway in angiogenesis in the ischaemic human heart. Cardiovasc Res 2012;93(Suppl):S76
81. Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009;2:ra81
82. Costa M, Cortez-Dias N. Carrilho-Ferreira P, et al. miR-375: novel biomarker for early prognostic stratification of acute myocardial infarction. Cardiovasc Res 2012;93(Suppl):S11